Description:

Fifteen years ago, Canada embarked on a collaborative journey to enhance the diagnosis and management of rare diseases, aiming to deliver precision health to patients and their families. Through innovative, large-scale interdisciplinary collaborations, Canadian initiatives advanced omic technologies, national and international data sharing, and functional studies propelling the country to the forefront of the global stage. Looking ahead to the next fifteen years, we must build on this progress and apply the lessons we’ve learned to drive the integration of genomics across all health sectors, accelerate the development of innovative treatments, and ensure comprehensive support for patients and their families to live their best lives. The road ahead is challenging, but by working together, we can make a meaningful and lasting impact.

Objectives

At the end of the session, participants will be able to:

  • Examine the impact of large-scale interdisciplinary collaborations on the diagnosis and discovery of rare diseases.
  • Explore the upcoming challenges in rare disease precision health over the next decade and identify collaborative strategies to address them.

Target Audience: Clinical Geneticists, Laboratory Geneticists, Genetic Counsellors, Trainees, Molecular Pathologists, Medical Lab Technologists
CanMEDS Roles: Medical Expert (the integrating role), Communicator, Collaborator, Leader, Health Advocate, Scholar, Professional

Speaker: Dr. Kym Boycott

Event Timeslots (1)

Day 1
-
KC 101-103-105 - Dr. Kym Boycott